Eptacog Alfa (Activated)
ATC B02BD08 · 3 markets · 23 records
GB 11 records · 5 strengths
- 8 mginjectionNovoSeven 8mg (400,000units) powder and solvent for solution for injection pre-filled syringesNovoSeven 8mg (400,000units) powder and solvent for solution for injection vials
- 5 mginjectionNovoSeven 5mg (250,000units) powder and solvent for solution for injection pre-filled syringesNovoSeven 5mg (250,000units) powder and solvent for solution for injection vials
- 2 mginjectionNovoSeven 2mg (100,000units) powder and solvent for solution for injection pre-filled syringesNovoSeven 2mg (100,000units) powder and solvent for solution for injection vials
- 1 mginjectionNovoSeven 1mg (50,000units) powder and solvent for solution for injection pre-filled syringesNovoSeven 1mg (50,000units) powder and solvent for solution for injection vials
Records without a stated strength · 1 NovoSeven 120,000unit powder and solvent for solution for injection vials、NovoSeven 240,000unit powder and solvent for solution for injection vials、NovoSeven 60,000unit powder and solvent for solution for injection vials
CA 8 records · 4 strengths
- 8 mgliquidNIASTASE RT
- 5 mgliquidNIASTASE RT
- 2 mgliquidNIASTASE RT
- 1 mgliquidNIASTASE RT
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 NovoSeven
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.